| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Experimental Pathology, Cancer Institute, 1-37-1 Kami-ikebukuro, Toshima-ku, ToKyo 170, Japan [Y. Ku., Y. Ki., O. H.], and Department of Cell Pathology, German Cancer Research Center, Heidelberg, Germany [F. K., P. B.]
Hereditary renal cell carcinomas invariably develop by the age of 1 year in Eker rats. At the histological level, renal cell carcinomas develop through multiple stages from early preneoplastic lesions (e.g., phenotypically altered tubules) to adenomas. We previously reported that ionizing radiation induces additional tumors (large adenomas and carcinomas) in a linear dose-response relationship and that loss of heterozygosity (LOH) at chromosome 10, where the predisposing tuberous sclerosis (Tsc2) gene is localized, was found in the renal cell carcinomas which developed from hybrid F1 rats carrying the Eker mutation, indicating that in heterozygotes two events (one inherited, one somatic) are necessary to produce at least large adenomas and carcinomas. This study was designed to examine LOH in the earliest preneoplastic lesions, using a laser microdissection procedure. We could accurately dissect single altered renal tubules out of freeze-dried sections and clearly detected LOH in 4 of 19 altered tubules (21%). This is the first demonstration of LOH in single renal tubules. Our present results support the theory of a second, somatic mutation (second hit) as rate-limiting step of renal carcinogenesis in the Eker rat model of dominantly inherited cancer and the tumor suppressor nature of the Tsc2 gene function.
1 This work was supported in part by a grant to Y. K. from the International Union Against Cancer (ICRETT) and Grants-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture of Japan and The Council for Tobacco Research, U.S.A.
2 To whom requests for reprints should be addressed.
Received 12/20/94. Accepted 1/24/95.
This article has been cited by other articles:
![]() |
C. Wilson, C. Bonnet, C. Guy, S. Idziaszczyk, J. Colley, V. Humphreys, J. Maynard, J. R. Sampson, and J. P. Cheadle Tsc1 Haploinsufficiency without Mammalian Target of Rapamycin Activation Is Sufficient for Renal Cyst Formation in Tsc1+/- Mice Cancer Res., August 15, 2006; 66(16): 7934 - 7938. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cai, J. I. Everitt, H. Kugo, J. Cook, E. Kleymenova, and C. L. Walker Polycystic Kidney Disease as a Result of Loss of the Tuberous Sclerosis 2 Tumor Suppressor Gene During Development Am. J. Pathol., February 1, 2003; 162(2): 457 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Yoon, T. J. Monks, J. I. Everitt, C. L. Walker, and S. S. Lau Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity Am J Physiol Renal Physiol, August 1, 2002; 283(2): F262 - F270. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kolb, S. H. Chang, and M. A. Davis Biochemical and Morphological Events During Okadaic Acid-Induced Apoptosis of Tsc2-Null ERC-18 Cell Line Toxicol Pathol, February 1, 2002; 30(2): 235 - 246. [Abstract] [PDF] |
||||
![]() |
A. K. Hodges, S. Li, J. Maynard, L. Parry, R. Braverman, J. P. Cheadle, J. E. DeClue, and J. R. Sampson Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin Hum. Mol. Genet., December 1, 2001; 10(25): 2899 - 2905. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Satake, T. Kobayashi, E. Kobayashi, K. Izumi, and O. Hino Isolation and Characterization of a Rat Homologue of the Human Tuberous Sclerosis 1 Gene (Tsc1) and Analysis of Its Mutations in RatRenal Carcinomas Cancer Res., February 1, 1999; 59(4): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kobayashi, H. Mitani, R.-i. Takahashi, M. Hirabayashi, M. Ueda, H. Tamura, and O. Hino Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene PNAS, April 15, 1997; 94(8): 3990 - 3993. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |